RBC Capital Remains Sidelined on Bojangles' (BOJA) Following 2Q

Jefferies Cuts Price Target on Bojangles' (BOJA) to $21; Reiterates Buy

Jefferies maintained a Buy rating on Bojangles' (NASDAQ: BOJA), and cut the price target to $21.00 (from $22.00), following the company's 2Q earnings report. Rest level margins were better than expected in 2Q and provided upside on lower food costs.

Analyst Andy Barish... More

Piper Jaffray Cuts price Target on Bojangles' (BOJA) to $16 Following 2Q EPS Beat

Piper Jaffray maintained a Neutral rating on Bojangles' (NASDAQ: BOJA), and cut the price target to $16.00 (from $17.00), following the company's 2Q earnings report. The company reported 2Q16 operating earnings of $0.27 vs. consensus expectations of $0.22 per share. Total revenues increased approximately 9.2% y/y to $131.6M.... More

After-Hours Stock Movers 08/08: (HIIQ) (CSLT) (ENDP) Higher; (TUBE) (MXL) (MTW) Lower (more...)

After-Hours Movers

Health Insurance Innovations (NASDAQ: HIIQ) 30% HIGHER; reported Q2 EPS of $0.27, $0.21 better than the analyst estimate of $0.06. Revenue for the quarter rose 95.6% to $44.5 million versus the consensus estimate of $37.11 million. GUIDANCE: Health Insurance Innovations sees FY2016 EPS of $0.55-$0.65, versus prior guidance of $0.38-$0.42 and the consensus of $0.43. Health Insurance Innovations sees FY2016 revenue of $155-165 million, versus prior guidance of $138-144 million and the consensus of $144.94 million.

TubeMogul (NASDAQ: TUBE) 21.6% LOWER; reported Q2 EPS of ($0.11), $0.04 worse... More

Bojangles' (BOJA) Tops Q2 EPS by 4c, Reduces FY Guidance

Bojangles' (NASDAQ: BOJA) reported Q2 EPS of $0.27, $0.04 better than the analyst estimate of $0.23. Revenue for the quarter came in at $131.6 million versus the consensus estimate of $132.77 million.

GUIDANCE:

Bojangles' sees FY2016 EPS of $0.88-$0.92, versus prior guidance of $0.89-$0.93 and the... More